Our Partnerships
-
CSSi are experts in successfully navigating the health authority and regulatory landscape for medical devices and have done so in numerous countries. Their team has obtained clearance for over 250 medical device technologies.
-
Stanford University will be the site of EDI’s lung cancer clinical trial for the EarlyTest.
Trial design is complete and approved by Stanford University. EDI is in preparation to initiate and execute the cancer clinical trial.
-
Alien Technology Transfer is an international industry consulting group, assisting EDI in securing non dilutive funding for clinical trials.